November 20, 2020

Patients with cancer are at increased risk for complications from the common flu. Plus, ensuring they receive recommended influenza vaccinations will reduce flu-related healthcare demands and decrease stress on the United States’ healthcare system, which is crucial as the nation approaches 10 million COVID-19 coronavirus cases. In response, the Centers for Disease Control and Prevention (CDC) isn’t waiting until National Influenza Vaccination Week, December 6–12, 2020, to promote vaccinations to high-risk populations.

November 17, 2020

Food connects us to other cultures, helps us celebrate life’s milestones, and nourishes our body. We spend hours of our day planning meals, cooking, and eating. With food at the center of our lives, a positive view of it promotes health and well-being, but many of us struggle with eating behaviors and weight management throughout our lifetime.

November 16, 2020

Lisa, a 32-year-old tax accountant, completed treatment for stage III triple-negative breast cancer 18 months ago. During a follow-up appointment, Lisa reported worsening headaches and difficulty concentrating at work. A magnetic resonance imaging scan and subsequent biopsy revealed a solitary brain lesion. She completed stereotactic brain radiation two months ago.

November 16, 2020

On November 13, 2020, the U.S. Food and Drug Administration (FDA) granted accelerated approval to pembrolizumab in combination with chemotherapy for the treatment of patients with locally recurrent unresectable or metastatic triple negative breast cancer (TNBC) whose tumors express PD-L1 (combined positive score [CPS] ≥ 10) as determined by an FDA-approved test. FDA also approved the PD-L1 IHC 22C3 pharmDx as a companion diagnostic for selecting patients with TNBC for pembrolizumab.

November 12, 2020

Over the summer, I coordinated a now all-too-familiar exercise: a Zoom call with multiple ONS Kansas-area chapter members, nurse experts, patient advocates, and elected officials. Spearheaded by the ONS National Office, we hosted an incredibly personal and informative conversation to discuss the COVID-19 coronavirus, how it affects patients with cancer, and the legislative and regulatory environment throughout our state.